- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Advances in Urology
Volume 2012 (2012), Article ID 421709, 8 pages
doi:10.1155/2012/421709
Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA
1Department of Urologic Surgery, Vanderbilt University, Nashville, TN 37203, USA
2Allergan Inc., P.O. Box 19534, Irvine, CA 92623, USA
3Xcenda, 4114 Woodlands Parkway Suite 500, Palm Harbor, FL 34685, USA
Received 2 December 2011; Accepted 22 February 2012
Academic Editor: Peter E. Clark
Copyright © 2012 Daniel A. Barocas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Daniel A. Barocas, Denise R. Globe, Danielle C. Colayco, et al., “Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA,” Advances in Urology, vol. 2012, Article ID 421709, 8 pages, 2012. doi:10.1155/2012/421709